
Intuitive Surgical (ISRG) Stock Forecast & Price Target
Intuitive Surgical (ISRG) Analyst Ratings
Bulls say
Intuitive Surgical's positive outlook is underscored by a 14% increase in Ion utilization and a notable growth of 35% in SP system utilization, illustrating robust demand for the company's innovative surgical solutions. The increase in gross margin guidance to 67-67.5%, driven by higher US system placements and a favorable tariff outlook, further enhances the company's financial health. Additionally, the growth in Da Vinci utilization, supported by the efficiency benefits of the D5 system, indicates strong procedural adoption and positions the company for sustained revenue growth.
Bears say
Intuitive Surgical's recent financial performance exhibits several red flags contributing to a negative outlook for the company's stock. Revenue from services fell short of expectations at $396 million, coupled with pressures from macroeconomic uncertainty that are leading hospitals to restrain or defer robotic purchasing decisions. Additionally, challenges such as market resistance to robotic surgical approaches, longer-than-anticipated rollouts of new systems, and tariff impacts from manufacturing in Mexico further complicate Intuitive Surgical's growth trajectory and overall financial stability.
This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.
Intuitive Surgical (ISRG) Analyst Forecast & Price Prediction
Start investing in Intuitive Surgical (ISRG)
Order type
Buy in
Order amount
Est. shares
0 shares